From Nasdaq: 2025-01-04 08:35:00

Investors are debating whether to stick with or double down on the Schwab US Dividend Equity ETF (SCHD) as top holdings like Pfizer, Coca-Cola, and AbbVie are analyzed. The Motley Fool Stock Advisor team did not include SCHD in their list of 10 best stocks to buy now, which have the potential for significant returns in the future. Stock Advisor has outperformed the S&P 500 since 2002, offering guidance on portfolio building and two new stock picks monthly. Mark Roussin, CPA, has positions in AbbVie, Coca-Cola, and SCHD. The Motley Fool has positions in and recommends AbbVie and Pfizer.

If you invest $1,000 in Schwab US Dividend Equity ETF, consider the insights shared by The Motley Fool to make an informed decision about your investment strategy.



Read more at Nasdaq: Time to Dump or Double Up on SCHD?